Qing H. Meng, Ph.D., M.D., DABCC, FADLM
Department of Laboratory Medicine, Division of Pathology-Lab Medicine Div
Present Title & Affiliation
Primary Appointment
Director, Department of Postdoctoral Clinical Chemistry Fellowship Program, Division of Pathology-Lab Medicine Div, The University of Texas MD Anderson Cancer Center, Houston, TX
Professor, Department of Laboratory Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX
Director, Department of Clinical Chemistry and Special Chemistry Laboratories, The University of Texas MD Anderson Cancer Center, Houston, TX
Education & Training
Degree-Granting Education
| 1999 | University of Helsinki, Helsinki, FI, Ph.D. in Medical Sciences |
| 1985 | Xuzhou Medical University, Jiangsu, CN, MD |
Postgraduate Training
| 2013-2014 | Faculty Leadership Academy, The University of Texas MD Anderson Cancer Center, Houston, Texas |
| 2010-2011 | Leadership and Management Succession Program, Saskatoon Health Region, Saskatoon |
| 2001-2003 | Clinical Chemistry, Postdoctoral Training Program, McMaster University, Hamilton |
| 1999-2001 | Research Fellowship, Postdoctoral Training, University of Toronto, Toronto |
Licenses & Certifications
| 2004 | American Board of Clinical Chemistry (Lifetime) |
| 2004 | Canadian Academy of Clinical Biochemistry |
Experience & Service
Faculty Academic Appointments
Director, Department of Pathology/Laboratory Medicine, Royal University Hospital, Saskatoon Health Region, College of Medicine, University of Saskatchewan, Saskatoon, 2011 - 2012
Clinical Professor, Department of Pathology/Laboratory Medicine, College of Medicine, University of Saskatchewan, Saskatoon, 2010 - 2012
Clinical Associate Professor, Department of Pathology/Laboratory Medicine, College of Medicine, University of Saskatchewan, Saskatoon, 2008 - 2010
Associate Director, Department of Pathology/Laboratory Medicine, Royal University Hospital, Saskatoon Health Region, Saskatoon, 2008 - 2011
Clinical Biochemist, Department of Pediatric Laboratory Medicine, The Hospital for Sick Children, Toronto, 2006 - 2008
Assistant Professor, Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, 2006 - 2008
Clinical Biochemist, Department of Pathology/Laboratory Medicine, Royal University Hospital, Saskatoon Health Region, Saskatoon, 2003 - 2006
Assistant Professor, Department of Pathology/Laboratory Medicine, University of Saskatchewan, Saskatoon, 2003 - 2006
Administrative Appointments/Responsibilities
Postdoctoral Fellow / Clinical Chemistry Diploma Program, Department of Pathology and Molecular Medicine, McMaster University, Hamilton, 2001 - 2003
Postdoctoral Fellow, Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, 1999 - 2001
Ph.D. Candidate, Department of Departments of Medicine and Clinical Chemistry, Helsinki Central Hospital, Faculty of Medicine, University of Helsinki, Helsinki, 1995 - 1999
Research Associate, Department of Pharmacology and Toxicology, Faculty of Medicine, University of Helsinki, Helsinki, 1993 - 1995
Physician (medicine and cardiology), Department of Medicine, Second People's Hospital of Lianyungang, Jiangsu, 1987 - 1993
Pediatrician, Department of Pediatrics, Second People's Hospital of Lianyungang, Jiangsu, 1985 - 1987
Other Professional Positions
Faculty, College of Graduate Studies, University of Saskatchewan, Saskatoon, 2004 - 2012
Intramural Institutional Committee Activities
Department Chair Search, Advisory Committee, The University of Texas MD Anderson Cancer Center, 2023 - 2025
Member, Beaker CP Steering Committee, The University of Texas MD Anderson Cancer Center, 2021 - Present
Committee, Medical Record Committee, The University of Texas MD Anderson Cancer Center, 2016 - Present
Extramural Institutional Committee Activities
Board Member, Cancer Diagnostics Monitoring, ADLM, 2025 - Present
Chair, Asia Pacific Subcommittee, ADLM, 2025 - Present
Senior Faculty, Senior Faculty Committee, The University of Texas MD Anderson Cancer Center, 2024 - Present
President, ADLM Academy, ADLM, 2024 - 2025
President Elect, ADLM (Formerly AACC Academy), The Academy of Diagnostics & Laboratory Medicine (ADLM), 2023 - 2024
Expert Panel, CLSI Clinical Chemistry and Toxicology, CLSI, 2023 - Present
Board, IFCC International Scientific Advisory Board (ISAB), IFCC, 2023 - 2025
Board Member, International Society of Oncology and Biomarkers, ISOBM, 2023 - Present
Chair, Cancer World Congress, Cancer World Congress, 2023
Inspector, CAP LAP inspection, CAP, 2022 - 2022
Member, Roche Scientific Advisory Committee, Roche Diagnostics, 2022
Chair, AACC Global Lab Quality Initiative Asia-Pacific Working Group, AACC, 2022 - 2025
Member, European Federation of Clinical Chemistry and Laboratory Medicine, European Federation of Clinical Chemistry and Laboratory Medicine, 2022 - Present
Consultant, World Health Organization, In Vitro Diagnostics, WHO, 2022 - Present
Member, FDA Medical Devices Advisory Committee, FDA, 2022 - Present
Editorial Activities
Co-Editor-in-Chief, The Electronic Journal of the International Federation of Clinical Chemistry and Laboratory Medicine, 2025 - Present
Section Editor, Annals of Medicine, 2020 - Present
Board Member, BMC Cancer, 2020 - Present
Associate Editor, Clinical Biochemistry, 2019 - Present
Editorial Board, Clinical Chemistry and Laboratory Medicine, 2017 - Present
Board Member, Frontiers in Laboratory Medicine, 2016 - Present
Board Member, Translational Cancer Research, 2016 - Present
Board Member, Journal of Applied Laboratory Medicine, 2016 - Present
Associate Editor, BMC Cancer, 2014 - 2020
Board Member, Clinical Biochemistry, 2014 - Present
Board Member, Critical Review in Clinical Laboratory Science, 2014 - Present
Board member, Journal of Bioscience and Medicine, 2012 - 2013
Board member, Journal of Clinical & Experimental Pathology, 2011 - Present
Lead Guest Editor, Journal of Biomedicine and Biotechnology, 2011 - 2012
Board member, Journal of Clinical Case Reports, 2011 - Present
Board member, Clinica Chimica Acta, 2008 - Present
Honors & Awards
| 2023 | The AACC 2023 Van Slyke Award, AACC NY-Metro Section |
| 2023 | Abbott Visiting Lecturer Award, IFCC- International Congress of the Turkish Biochemical Society (TBS) |
| 2022 | Founding Member Award, AACC Tumor Markers and Cancer Diagnostics Division |
| 2022 | Distinguished Contribution to Education Award, The North American Chinese Clinical Chemists Association |
| 2022 | AACC Texas Section Past Chair Award |
| 2022 | Past Chair Award, AACC |
| 2022 | Excellence in Service Award for Outstanding Contributions to the Profession of Clinical Chemistry, AACC Texas Section |
| 2021 | 2021 AACC Academy Award for Outstanding Contributions to Clinical Chemistry in a Selected Area of Research, AACC |
| 2020 | Clinical Chemist Recognition Award |
| 2019 | Past Division Chair Award, Nutrition Division,AACC, AACC |
| 2019 | Outstanding Research Award, The North American Chinese Clinical Chemists Association, NACCCA |
| 2018 | Outstanding Mentorship Award, The North American Chinese Clinical Chemists Association (NACCCA) |
| 2018 | Clinical Chemist Recognition Award, AACC |
| 2017 | Outstanding Contribution to Laboratory Medicine, Chinese Society of Laboratory Medicine |
| 2017 | Outstanding Contributions to Global Laboratory Quality, Wallace H. Coulter Foundation and AACC |
| 2017 | Clinical Chemist Recognition Award, AACC |
| 2016 | Clinical Chemist Recognition Award, AACC |
| 2015 | Canadian Academy of Clinical Biochemistry Award for Outstanding Service to the Profession of Clinical Biochemistry |
| 2015 | Clinical Chemist Recognition Award, AACC |
| 2014 | Patient Safety Abstract Award, AACC |
| 2014 | President's Recognition for Faculty Excellence, MD Anderson Cancer Center |
| 2013 | Outstanding Speaker Award, AACC |
| 2013 | Research Excellence Award, CSCC |
| 2012 | Outstanding Contribution Award, The North American Chinese Clinical Chemists Association (NACCCA) |
| 2012 | Excellence in Research and Best Abstract Award, AACC Nutrition Division |
| 2011 | International Exchange Grant Award, CSCC |
| 2011 | Rocky Mountain Section Scholarship, AACC |
| 2011 | Critical and Point-of-Care Testing Division and the Van Slyke Foundation Research Grant Award, AACC |
| 2008 | Best Poster Award, AACC Division of Animal Clinical Chemistry |
| 2008 | Distinguished Abstract Award (x2), NACB |
| 2007 | Clinical Chemist Recognition Award, AACC |
| 2006 | Distinguished Abstract Award, NACB |
| 2003 | Clinical Chemists Travel Award, Ontario Society |
| 2003 | Research Award, Dutkevich Memorial Trust Fund (McMaster University) |
| 2002 | Clinical Chemists Award, Canadian Society |
| 2002 | Best Poster Award, Canadian Society of Clinical Chemists |
| 1998 | Conference Travel Award, University of Helsinki |
| 1997 | Chancellor's Research Award, University of Helsinki |
Professional Memberships
Selected Presentations & Talks
Local Presentations
- 2023. Using Routine Laboratory Tests in Monitoring and Management of COVID-19 Patients. Conference. AACC Texas Section Conference. League City, Texas, US.
- 2022. Using Routine Laboratory Tests in Monitoring and Management of COVID-19 Patients. Conference. AACC Texas Section Conference. League City, Texas, US.
- 2021. Standardization of Plasma PTH and FNA Wash Out PTH Specimen Collection. Invited. Standardization of Plasma PTH and FNA Wash Out PTH Specimen Collection. HOUSTON, TX, US.
- 2021. Standardization of Plasma PTH and FNA Wash Out PTH Specimen Collection. Conference. Multidisciplinary Parathyroid Neoplasia Conference. Houston, Texas, US.
- 2020. Factors May Impact IOPTH Results and Interpretation. Conference. Multidisciplinary Parathyroid Neoplasia Conference. Houston, Texas, US.
- 2019. Total Laboratory Automation in Clinical Chemistry Laboratory. Conference. AACC Texas Section Conference. Cedar Creek, Texas, US.
- 2016. Circulating Tumor Cells: Clinical Utility, Challenges, and Future Perspective. Conference. UTMB Pathology Grand Round. Houston, Texas, US.
- 2015. Parathyroid Hormone: Impact of Pre-analytical and Analytical Factors on Measurement. Conference. Multidisciplinary Parathyroid Neoplasia Conference. Houston, Texas, US.
- 2015. Preanalytical Errors and Quality Improvement. Conference. 2015 TACLS Annual Meeting. Houston, Texas, US.
- 2013. Methylglyoxal (MG): Role in Diabetes and Diabetic Complications. Conference. Galveston, Texas, US.
- 2013. Laboratory Approaches to the Management of Diabetic Emergencies. Panelist. AACC Annual Meeting. Houston, Texas, US.
- 2013. Laboratory Approaches in Monitoring Chemotherapy-Induced Organ Injury. Conference. AACC Annual Meeting. Houston, Texas, US.
- 2011. Pseudohyperkalemia: a New Twist on an Old Phenomenon. Conference. MD Anderson Cancer Center. Houston, Texas, US.
National Presentations
- 2025. Laboratory Approaches for Monitoring Efficacy and Toxicities in Cancer Immunotherapy. Invited. ADLM Annual Conference 2025. Chicago, IL, US.
- 2025. Improving Laboratory Performance through Education, Training, and Quality Management: Experience from Asia-Pacific Working Group. Invited. ADLM Annual Conference 2025. Chicago, IL, US.
- 2024. Biomarker-Based Integrated Diagnostic Approach in Oncology. Conference. Rochester, Minnesota, US.
- 2021. Role of Routine and Ancillary Laboratory Testing in Monitoring Immunotherapy. Conference. AACC Annual Scientific Meeting. Atlanta, Georgia, US.
- 2021. Role of Routine and Ancillary Laboratory Testing in Monitoring Immunotherapy. Conference. AACC Annual Scientific Meeting. Atlanta, Georgia, US.
- 2019. Laboratory Strategies for Mitigating Pre-Analytical Errors. Conference. AACC Annual Meeting. Anaheim, California, US.
- 2018. Maximizing Laboratory Efficiencies by Implementing Front-End Automation with Focus on Go-Live Hiccups. Conference. AACC Annual Meeting. Chicago, Illinois, US.
- 2017. Circulating Tumor Cells: Clinical Utility, Challenges, and Future Prospects. Conference. 2017 Cancer Research & Oncology Virtual Conference, US.
- 2017. Abnormal Routine Laboratory Results and Interpretation in Cancer Patients. Conference. AACC Annual Meeting. San Diego, California, US.
- 2017. Quality Control Rules and Practical Exercises Global Lab Quality Initiative Mini-Workshop. Conference. AACC Annual Meeting. San Diego, California, US.
- 2017. Biomarkers of Cancer Therapy Induced Cardiotoxicity. Conference. AACC Annual Meeting. San Diego, California, US.
- 2017. Using New Technology for Circulating Tumor Cell Detection in Cancer Therapy. Conference. AACC Annual Meeting. San Diego, California, US.
- 2013. Lean Journey to Laboratory Quality Improvement. Conference. AACC Texas Section Fall 2013 Conference. Galveston, Texas, US.
- 2012. Metformin Attenuates Neointimal Formation in Fructose-Induced Insulin Resistant Rats: the Pathological Role of Methylglyoxal in Stenosis. Conference. AACC Nutrition Division. Los Angeles, California, US.
- 2011. Pseudohyperkalemia: a New Twist on an Old Phenomenon. Conference. Los Angeles, California, US.
- 2008. Beneficial Effects of Soy Isoflavones on Glucose Control and Complication Prevention in Diabetic Rats. Conference. Center Valley, Pennsylvania, US.
- 2008. Transforming Growth Factor-B1 is a Potential Marker for Kidney Damage in Patients With Essential Hypertension: Renoprotective Effect of ACE Inhibitor And/Or Angiotensin II Receptor Blocker. Conference. 2008 AACC Annual Meeting. Washington, D.C, District of Columbia, US.
- 2005. New Biomarkers of Ischemic Heart Disease: The Era Beyond Troponin (2005XIX). Conference. IFCC/AACC. Orlando, Florida, US.
International Presentations
- 2025. Optimizing Biochemical Tumor Biomarker Testing and Interpretation: CLSI guideline-based approach. Conference. 47th Conference of the ISOBM. Murnau, DE.
- 2025. Recent Advances in the Use of Biochemical Tumor Markers in Cancer Practice. Conference. 47th Conference of the ISOBM. Murnau, DE.
- 2025. Update of Biochemical Tumor Marker Testing in Cancer Practice. Conference. IFCC-ELFM EuroMedLab 2025. Brussels, BE.
- 2025. Laboratory personnel Training and Competency. Conference. APWG Workshop at 5th Nepalese Association of Clinical Chemistry (NACC) Conference. Kathmandu, NP.
- 2025. Quality Indicators in Laboratory Medicine: Driving Excellence in Laboratory Service Service and Patient Care. Conference. APWG Workshop at 5th Nepalese Association of Clinal Chemistry (NACC) Conference. Kathmandu, NP.
- 2025. Optimizing Biochemical Tumor Biomarker Testing and Interpretation. Invited. International Society of Oncology and Biomarker, US.
- 2025. Finding Optimal Approaches in Tumor Biomarker Testing and Result Interpretation. Conference. Labquality Days. Helsinki, FI.
- 2024. Integrated Diagnostics of Tumor Markers in Cancer Practice. Conference. Department of Clinical Biochemistry. New Delhi, IN.
- 2024. External quality assessment performance in ten countries: An IFCC Global Laboratory Quality Project. Conference. 50th ACBICON: Golden Jubilee Conference of Association of Clinical Biochemist of India. Chandigarh, IN.
- 2024. Improving Global Laboratory Quality: The Strategies and Approaches of The IFCC Task Force on Global Lab Quality (TF-GLQ). Conference. 50th ACBICON 2024: Golden Jubilee Conference of Association of Clinical Biochemists of India. Chandigarh, IN.
- 2023. IFCC Visiting Lecture: TBS International Biochemistry Congress. Invited. 34th National Biochemistry Congress. Fethiye, TR.
- 2023. IFCC Global Lab Quality Workshops. Conference. IFCC Global Lab Quality Workshop. Lima, PE.
- 2023. Adding Value to Patient Care Using Quality Control. Conference. 2023 GLQI Asia-Pacific Working Group Workshop. Ulaanbaatar, MN.
- 2023. Current Practice and Challenges of Tumor Markers. Conference. 7th Cancer World Congress Meeting. Italy, US.
- 2022. Career Opportunity for Clinical Chemist in the US. Conference. ACBICON 2022 Conference. New Delhi, IN.
- 2022. Quality Control: Strategy and Practice for Clinical Laboratories. Conference. ACBICON 2022 Conference. New Delhi, IN.
- 2022. The Global Lab Quality: International Federation of Clinical Chemistry and Laboratory Medicine. Conference. International Federation of Clinical Chemistry and Laboratory Medicine (IFCC) General Conference. Brussels, BE.
- 2021. Implementation of Front-End Automation in Clinical Chemistry Laboratory. Invited. 15th APFCB Conference. Jaipur, IN.
- 2019. Total Laboratory Automation in Clinical Chemistry Laboratory. Conference. AACC India Conference. Mumbai, IN.
- 2019. The Implication of Routine Laboratory Results in Oncology. Invited. 15th APFCB Conference. Jaipur, IN.
- 2018. How to Generate SCI Publications from Routine Laboratory Data. Conference. Chinese Society of Laboratory Medicine Annual National Congress of Laboratory Medicine. Dalian, CN.
- 2018. An Overview of Clinical Laboratories in the United States: Structure, Operation, and Accreditation of Labs, and the Trends in Laboratory Medicine. Conference. 2018 Annual Meeting of Chinese Medical Doctor Association of Laboratory Medicine. Fuzhou, CN.
- 2017. Biomarkers for Metastatic Bone Disease and Cancer Therapy Related Bone Disease. Conference. IFCC WorldLab. Durban, ZA.
- 2017. Training, Certification, Practice, and Responsibility of Clinical Pathologists in the US. World Association of Chinese Doctors. Conference. Qingdao, CN.
- 2015. An Overview of Laboratory Professionals in the United States: Education, Certification, and Practice. Conference. 11th National Laboratory Medicine Conference. Nanjing, CN.
- 2013. The Analytical Complexities and Clinical Impacts of HCG Tests. Conference. Wenzhou, CN.
- 2013. An Overview of Laboratory Professionals in the United States: Education, Certification, and Practice. Conference. Wenzhou, CN.
- 2013. Clinical Applications of Liquid Chromatography-Tandem Mass Spectrometry. Conference. KingMed Diagnostics. Guangzhou, CN.
- 2011. Pseudohyperkalemia: a New Twist on an Old Phenomenon. Conference. Canadian Laboratory Medicine Congress. Vancouver, CA.
- 2011. D-Lactic Acidosis: A New Insight into an Old Phenomenon. Conference. AACC Rocky Mountain Section 2011. Saskatoon, CA.
- 2011. What Is New In Pediatric Diagnostic Testing And Its Reference Intervals?. Conference. AACC Rocky Mountain Section 2011. Saskatoon, CA.
- 2010. Atherosclerosis and Biomarkers of Cardiovascular Disease. Conference. Wenzhou, CN.
- 2009. Methylglyoxal: Role in Diabetes and Insulin resistance. Conference. 2009 CSCC Travelling Lecturship organized by MSCC-Manitoba Society of Clinical Chemists. Winnipeg, CA.
- 2006. Protective Role of Gasotransmitter Hydrogen Sulfide (H2S) in Cardiovascular System. Conference. University of Toronto, CA.
- 2005. The Role of Biochemical Markers in the Diagnosis of Acute Coronary Syndromes. Conference. Jiangsu, CN.
- 2005. Mechanisms of the Development of Atherosclerosis and Restenosis. Conference. Zhenjiang, CN.
- 2005. New Biochemical Markers in the Diagnosis of Acute Coronary Syndromes. Conference. Jinan, CN.
- 2005. Role of Matrix Formation in the Pathogenesis of Atherosclerosis and Restenosis. Conference. Jinan, CN.
- 2004. New Biomarkers of Ischemic Heart Disease: The Era Beyond Troponin. Conference. 2004 Canadian Society of Clinical Chemists annual Conference. London, CA.
Formal Peers
- 2021. Role of Routine and Ancillary Laboratory Testing in Monitoring Immunotherapy. Invited. Atlanta, GA, US.
- 2020. Clinical Laboratories in the US: Operation, Regulation, Accreditation, and Management. Invited, US.
- 2020. An Overview of Tumor Markers. Invited, US.
- 2020. An Update of Cancer Biomarkers. Invited, US.
- 2014. Hypercalcemia: Causes and Laboratory Approach. Invited. Toronto, CA.
- 2013. Methylglyoxal (MG): Role in Diabetes and Diabetic Complications. Invited. Galveston, TX, US.
- 2011. Pseudohyperkalemia: a New Twist on an Old Phenomenon. Invited. Los Angeles, CA, US.
- 2011. Pseudohyperkalemia: a New Twist on an Old Phenomenon. Invited. Calgary, CA.
- 2011. Pseudohyperkalemia: a New Twist on an Old Phenomenon. Invited. Houston, TX, US.
- 2009. Methylglyoxal: Role in Diabetes and Insulin resistance. Invited. Winnipeg, CA.
- 2006. Protective Role of Gasotransmitter Hydrogen Sulfide (H2S) in Cardiovasculat System. Invited. Toronto, CA.
Grant & Contract Support
| Date: | 2026 - 2028 |
| Title: | Developing an AI-based Clinical Risk-Adaptive Forecasting Tool for Prostate Cancer |
| Funding Source: | AMERICAN CANCER SOCIETY, NATIONAL |
| Role: | Key |
| Date: | 2026 - 2026 |
| Title: | Developing AI-Driven Personalized Early Detection and Clinical Decision Support for Prostate Cancer |
| Funding Source: | NATIONAL INSTITUTES OF HEALTH |
| Role: | Key |
| Date: | 2023 - 2025 |
| Title: | Longitudinal Assessment of Cardiac Injury and Cardiac Fitness in LA-NSCLC Patients Receiving Model Based Personalized chemoRadiation – an Adaptive Cohort Registration Study |
| Funding Source: | Roche Diagnostics Grant |
| Role: | Co-PI |
| Date: | 2021 - 2026 |
| Title: | Risk prediction and longitudinal assessment of cardiotoxicity and functional capacity trajectory in NSCLC patients |
| Funding Source: | NIH/NCI |
| Role: | Co-PI |
| ID: | 5R01HL157273 |
| Date: | 2019 - 2021 |
| Title: | Performance evaluation of Beta HCG as a tumor marker |
| Funding Source: | NACCCA |
| Role: | Co-PI |
| Date: | 2019 - 2021 |
| Title: | NIH R21/Understanding the effect of protons and photons on heart injury |
| Funding Source: | NIH/NCI |
| Role: | Co-PI |
| Date: | 2019 - 2024 |
| Title: | The CASPAR study validation and clinical trial of Chromogranin A |
| Funding Source: | Thermo Fisher Scientific |
| Role: | Co-PI |
| Date: | 2018 - 2022 |
| Title: | Develop CTC capture technology for both mesenchymal and non-mesenchymal tumors |
| Funding Source: | NIH |
| Role: | Co-PI |
| ID: | R 1R01EB026291-01A1 |
| Date: | 2017 - 2019 |
| Title: | High Sensitivity Troponin T to monitor radiation therapy-induced cardiotoxicity |
| Funding Source: | Roche Diagnostic Grant |
| Role: | Co-PI |
| Date: | 2015 |
| Title: | HE4 and CA125 in risk assessment of ovarian cancer |
| Funding Source: | Fujirebio Diagnostics, Inc |
| Role: | PI |
| Date: | 2015 - 2017 |
| Title: | Cancer Cell Surface Vimentin (CCSV) as a Universal CTC Marker for Sarcoma Metastasis Detection and Genetic Mutation Analysis |
| Funding Source: | MD Anderson Institutional Research Grant |
| Role: | PI |
| Date: | 2014 |
| Title: | Multivariate Prediction of Prostate Cancer in Puerto Rican and African American Men |
| Funding Source: | Beckman Coulter Grant |
| Role: | PI |
| Date: | 2013 - 2016 |
| Title: | Multivariate Prediction of Prostate Cancer in Puerto Rican and African American Men |
| Funding Source: | National Cancer Institute (NCI) |
| Role: | Co-I |
| Date: | 2013 |
| Title: | High Sensitivity Troponin T to monitor doxorubicin-induced cardiotoxicity (RD001857) |
| Funding Source: | Roche Diagnostic Grant |
| Role: | PI |
| Date: | 2013 - 2018 |
| Title: | Serum miRNAs as Biomarkers in the Early Detection and Prognosis of Prostate Cancer |
| Funding Source: | M D Anderson Cancer Center |
| Role: | PI |
| Date: | 2012 - 2014 |
| Title: | Glucose byproduct levels in patients treated with metformin for diabetes and their association with biomarkers of vascular endothelial damage |
| Funding Source: | Royal University Hospital Foundation |
| Role: | Co-PI |
| Date: | 2011 - 2015 |
| Title: | Closing the Critical Gaps in Pediatric Reference Intervals for Laboratory Biomarkers of Pediatric Disease: The Canadian Laboratory Initiative on Pediatric Reference Intervals (CALIPER) |
| Funding Source: | Canadian Institute of Health Research (CIHR) |
| Role: | Co-PI |
| Date: | 2011 |
| Title: | D-Lactate Predicts the Severity of Diabetic Ketoacidosis |
| Funding Source: | AACC Critical and Point-of-Care Testing Division and the Van Slyke |
| Role: | PI |
| Date: | 2010 |
| Title: | CALIPER: Closing the Gaps in Pediatric Reference Intervals |
| Funding Source: | Canadian Institute of Health Research (CIHR) |
| Role: | Co-I |
| Date: | 2010 - 2012 |
| Title: | ESTABLISHMENT OF A LABORATORY REFERENCE INTERVAL DATABASE FOR BIOMARKERS OF PEDIATRIC DISEASE IN SASKATOON HEALTH REGION (SHR) |
| Funding Source: | Royal University Hospital Foundation |
| Role: | PI |
| Date: | 2010 - 2012 |
| Title: | Establishment of Pediatric Reference on Roche Cobas System |
| Funding Source: | College of Medicine, University of Saskatchewan |
| Role: | PI |
| Date: | 2010 - 2012 |
| Title: | BioNEMS - Biological Nano Electrical Mechanical System |
| Funding Source: | Saskatchewan Health Research Foundation |
| Role: | Co-I |
| Date: | 2008 - 2011 |
| Title: | Methylglyoxal (MG), A Key Mediator of Diet-induced Insulin Resistance, Dyslipidemia, and Atherosclerosis |
| Funding Source: | Heart and Stroke Foundation of Canada (Ontario & Saskatchewan) |
| Role: | PI |
| Date: | 2008 |
| Title: | Saskatchewan Health Grants |
| Funding Source: | Saskatchewan Health Grants |
| Role: | PI |
| Date: | 2007 |
| Title: | Charles Hollenberg Summer Studentship Program |
| Funding Source: | Banting and Best Diabetes Centre |
| Role: | PI |
| Date: | 2007 |
| Title: | Start-up Operating Grant-Department of Laboratory Medicine and Pathobiology |
| Funding Source: | University of Toronto |
| Role: | PI |
| Date: | 2007 |
| Title: | Dean's Fund |
| Funding Source: | University of Toronto |
| Role: | PI |
| Date: | 2007 |
| Title: | Start-up Operation Grant |
| Funding Source: | Hospital for Sick Children |
| Role: | PI |
| Date: | 2005 |
| Title: | Plasma Lipid Profiles Change During Cardiac Catheterization and Intracoronary Thrombolysis |
| Funding Source: | Royal University Hospital Foundation |
| Role: | PI |
| Date: | 2005 |
| Title: | Protective Role of Hydrogen Sulfide in Atherosclerosis |
| Funding Source: | Canada Foundation for Innovation (CFI) |
| Role: | Investigator |
| Date: | 2005 |
| Title: | Impact of Implementing Cardiac Troponin Testing Algorithm on Excessive And Inappropriate Troponin Test Requests |
| Funding Source: | Health Quality Council Innovation Fund (Saskatchewan) |
| Role: | PI |
| Date: | 2005 |
| Title: | Supplemental Capital Equipment Start-up Fund-University of Saskatchewan |
| Funding Source: | Supplemental Capital Equipment Start-up Fund-University of Saskatchewan |
| Role: | PI |
| Date: | 2005 - 2007 |
| Title: | CIHR/Heart Stroke Foundation of Canada |
| Funding Source: | GREAT program scholarship |
| Role: | Supervisor |
| Date: | 2005 |
| Title: | Supplemental Capital Equipment Start-up Fund |
| Funding Source: | University of Saskatchewan |
| Role: | PI |
| Date: | 2005 - 2008 |
| Title: | Protective Role of H2S in the Development and Progression of Atherosclerosis and Stenosis |
| Funding Source: | Heart and Stroke Foundation of Canada (Saskatchewan) |
| Role: | Investigator |
| ID: | (#404923) |
| Date: | 2005 - 2007 |
| Title: | Role of H2S in Atherosclerosis and Thrombosis |
| Funding Source: | Saskatchewan Health Research Foundation |
| Role: | PI |
| ID: | (#405226) |
| Date: | 2004 |
| Title: | Start-up Operating Grant Capital Equipment |
| Funding Source: | University of Saskatchewan |
| Role: | PI |
| Date: | 2004 |
| Title: | Start-up Operating Grant |
| Funding Source: | College of Medicine, University of Saskatchewan |
| Role: | PI |
| Date: | 2004 |
| Title: | Start-up Operation Grant |
| Funding Source: | University of Saskatchewan |
| Role: | PI |
| Date: | 1999 |
| Title: | Chancellor's Research Grant |
| Funding Source: | University of Helsinki |
| Role: | PI |
| Date: | 1998 |
| Title: | 350th Anniversary Foundation Grant |
| Funding Source: | University of Helsinki |
| Role: | PI |
| Date: | 1996 |
| Title: | Chancellor's Research Grant |
| Funding Source: | University of Helsinki |
| Role: | PI |
Selected Publications
Peer-Reviewed Articles
- Chen L, Ibrahim NGE, Tang G, Meng QH, Hu Z. Aberrant Plasma Cells in the Absence of M-Protein: Ancillary Testing Beyond Protein Electrophoresis. Clin Chem 71(2):1195-1199, 2025. e-Pub 2025. PMID: 41329021.
- Chen L, Meng QH. Advancing Laboratory Diagnosis for Future Pandemics: Challenges and Innovations. Pathogens, 2025. e-Pub 2025. PMID: 41305372.
- Gan Q, Ding Y, Wu Y, Zhang Y, Meng QH, Ding QQ, Lu H, Shelburne SA, Ehlers RA, Han XY. Infections Due to Corynebacterium Kroppenstedtii With Focus on Granulomatous Lobular Mastitis for Tissue Specificity, Pathogenesis, Bacteriologic Workup, and Treatment. Arch Pathol Lab Med 149(9):812-821, 2025. e-Pub 2025. PMID: 39800878.
- Chen L, Zhang Y, Meng QH. Persistent AST Elevation in a Patient with Ovarian Cancer: A Rare Diagnostic Challenge. Journal of Clinical Laboratory Analysis 39(15):e70072, 2025. e-Pub 2025. PMID: 40552755.
- Chen L, Zhang Y, Meng QH. Persistent Hypoglycemia and Lactic Acidosis in Lymphoma: Implications of the Warburg Effect. Mayo Clinic Proceedings 100(7):1257-1259, 2025. e-Pub 2025. PMID: 40610116.
- Giannoli JM, Vassault A, Carobene A, Perret Liaudet, Blasutig IM, Dabla PK, Lin J, Thomas A, Poloni JAT, Meng QH, Amann EP, IFCC, TF-GLQ. Ensuring internal quality control practices in medical Laboratories: IFCC recommendations for practical applications based on ISO 15189:2022. Clinica Chimica Acta 571, 2025. e-Pub 2025. PMID: 40064457.
- Van Rossum, HH, Holdenrieder, S, Yun, YM, Patel, D, Thelen, M, Song, J, Unsworth, N, Partridge, K, Moore, M, Cui, W, Ramanathan, LV, Meng, QH, Ballieux, BE, Sturgeon, CM, Vesper, HW. External quality assessment-based tumor marker harmonization simulation; Insights in achievable harmonization for CA 15-3 and CEA. Clinical Chemistry and Laboratory Medicine 63(2):410-421, 2025. e-Pub 2024. PMID: 39299928.
- Chen L, Zhang Y, Meng QH. Prostate cancer in men under 50: the impact of race/ethnicity and family history. Ann Med 57(1):2536202, 2025. e-Pub 2025. PMID: 40689716.
- Chen, L, Zhang, Y, Meng, QH. Cherry Red Plasma. Clinica Chimica Acta 564, 2025. e-Pub 2025. PMID: 39181292.
- Meng QH, Halfdanarson TR, Bornhorst J, Jann H, Shaheen S, Shi RZ, Schwabe A, Stade K, Halperin DM. Circulating Chromogranin A as a Surveillance Biomarker in Patients with Carcinoids-The CASPAR Study. Clin Cancer Res 30(24):5559-5567, 2024. e-Pub 2024. PMID: 39453770.
- Bais R, Vassault A, Blasutig IM, Dabla PK, Lin J, Perret-Liaudet A, Thomas A, Cendejas KA, Wheeler SE, Giannoli JM, Meng QH, Amann EP. External quality assessment performance in ten countries: an IFCC global laboratory quality project. Clin Chem Lab Med 62(12):2435-2443, 2024. e-Pub 2024. PMID: 39238208.
- Gu J, Cheryl L, Nogueras González GM, Huff C, Strom S, Jones JA, Griffith DP, Canfield SE, Wang X, Huang X, Roberson P, Meng QH, Troncoso P, Ittmann M, Covinsky M, Scheurer M, Ramirez MI, Pettaway CA. A West African Ancestry-Associated SNP on 8q24 Predicts A Positive Biopsy In African American Men With Suspected Prostate Cancer Following PSA Screening. Prostate 84(7):694-705, 2024. e-Pub 2024. PMID: 38477020.
- Huub HVR, Holdenrieder S, Ballieux BEPB, Badrick TC, Yun YM, Zhang C, Patel D, Thelen M, Song J, Wojtalewicz N, Unsworth N, Vesper HW, Cui W, Ramanathan V L, Sturgeon C, Meng QH. Investigating the current harmonization status of tumor markers using global external quality assessment programs: A feasibility study. Clin Chem 70(4):669-679, 2024. e-Pub 2024. PMID: 38385453.
- Ondracek CR, Melanson SEF, Doan L, Schulz M K, Kleinman S, Zhao Z, Kumanovics A, Wu AHB, Wiencek J, Meng QH, Apple FS, Koch D, Vesper H, Pokuah F, Bryksin J, Myers GL, Christenson R, Zhang YV. Large-Scale Scientific Study Led by a Professional Organization during the COVID-19 Pandemic: Operations, Best Practices, and Lessons Learned. J Appl Lab Med 9(2):371-385, 2024. e-Pub 2024. PMID: 38059919.
- Zhang, YV, Kumanovics, A, Wiencek, J, Melanson, SE, Love, T, Wu, AH, Zhao, Z, Meng, QH, Koch, D, Apple, FS, Ondracek, CR, Christenson, R. Performance of Three Anti-SARS-CoV-2 Anti-S and One Anti-N Immunoassays for the Monitoring of Immune Status and Vaccine Response. Viruses 16(2), 2024. e-Pub 2024. PMID: 38400067.
- Qian X, Meng QH. Circulating lung cancer biomarkers: From translational research to clinical practice. Tumour Biol 46(S1):S27-S33, 2024. e-Pub 2024. PMID: 37927289.
- Yang HS, Pan W, Wang Y, Zaydman MA, Spies NC, Zhao Z, Guise TA, Meng QH, Wang F. Generalizability of a Machine Learning Model for Improving Utilization of Parathyroid Hormone-Related Peptide Testing across Multiple Clinical Centers. Clin Chem 69(11):1260-1269, 2023. e-Pub 2023. PMID: 37738611.
- Qian X, Meng QH. Circulating Lung Cancer Biomarkers: From Translational Research to Clinical Practice. Tumour Biol 46(s1):S27-S33, 2023. e-Pub 2023. PMID: 37927289.
- Blasutig IM, Wheeler SE, Bais R, Dabla PK, Lin J, Perret-Liaudet A, Thomas A, Cendejas KA, Giannoli JM, Vassault A, Amann E, Meng QH. External Quality Assessment Practices in Medical Laboratories: An IFCC Global Survey of Member Societies. Clinical Chemistry and Laboratory Medicine 61(8):1404-1410, 2023. e-Pub 2023. PMID: 36779362.
- Wheeler SE, Blasutig IM, Dabla PK, Giannoli JM, Vassault A, Lin J, Cendejas KA, Perret-Liaudet A, Bais R, Thomas A, Amann EP, Meng QH. Quality Standards and Internal Quality Control Practices in Medical Laboratories: An IFCC Global Survey of Member Societies. Clin Chem Lab Med 61(12):2094-2101, 2023. e-Pub 2023. PMID: 37327359.
- Zhao Z, Meng QH, Kumanovics A, Love T, Melanson SEF, Wu AHB, Wiencek J, Apple F, Ondracek CR, Koch DD, Christenson RH, Zhang YV. T Cell Responses Correlate with Self-Reported Disease Severity and Neutralizing Antibody Responses Predict Protection against SARS-CoV-2 Breakthrough Infection Viruses. Viruses 15(3):709, 2023. e-Pub 2023. PMID: 36992418.
- Franks CE, Li J, Martinez M, Farnsworth CW, Jones PM, Grenache DG, Meng QH, Gronowski AM. Utility of Commercially Available Quantitative hCG Immunoassays as Tumor Markers in Trophoblastic and Non-Trophoblastic Disease. Clin Chem Lab Med 69(6):606-614, 2023. e-Pub 2023. PMID: 37205831.
- Koutroumpakis E, Xu T, Lopez-Mattei J, Pan T, Lu Y, Irizarry-Caro JA, Mohan R, Zhang X, Meng QH, Lin R, Xu T, Deswal A, Liao Z. Coronary artery calcium score on standard of care oncologic CT scans for the prediction of adverse cardiovascular events in patients with non-small cell lung cancer treated with concurrent chemoradiotherapy. Front Cardiovasc Med 9:1071701, 2022. e-Pub 2022. PMID: 36531700.
- Melanson SEF, Zhao Z, Kumanovics A, Love T, Meng QH, Wu AHB, Apple F, Ondracek CR, Schulz KM, Wiencek JR, Koch D, Christenson R, Zhang YV. Tolerance for three commonly administered COVID-19 vaccines by healthcare professionals. Front Public Health 10:975781, 2022. e-Pub 2022. PMID: 36238255.
- Hilaire MR, Gill RV, Courtney JB, Baburina I, Gardiner J, Milone MC, Shaw LM, Meng QH, Salamone SJ. Evaluation of a Nanoparticle-Based Busulfan Immunoassay for Rapid Analysis on Routine Clinical Analyzers. Ther Drug Monit 43(6):766-771, 2021. e-Pub 2021. PMID: 33814542.
- Xu T, Meng QH, Gilchrist SC, Lin SH, Lin R, Xu T, Milgrom SA, Gandhi GJ, Wu H, Zhao Y, Lopez-Mattei JC, Mohan R, Liao Z. Assessment of Prognostic Value of High-Sensitivity Cardiac Troponin T for Early Prediction of Chemoradiotherapy-Induced Cardiotoxicity in Non-Small Cell Lung Cancer Patients: A Secondary Analysis of a Prospective Randomized Trial. Int J Radiat Oncol Biol Phys 111(4):907-916, 2021. e-Pub 2021. PMID: 34302893.
- Rossum HHV, Meng QH, Ramanathan LV, Holdenrieder S. A word of caution on using tumor biomarker reference change values to guide medical decisions and the need for alternatives. Clin Chem Lab Med 60(4):553-555, 2021. e-Pub 2021. PMID: 34648697.
- Meng, QH. Are Arterial Blood Samples Acceptable for Chemistry Testing in Laboratory Practice?. The journal of applied laboratory medicine 6(5):1380-1383, 2021. e-Pub 2021. PMID: 34313299.
- Meng QH. Development of an automated nanoparticle assay and Bayesian-based tool for rapid busulfan pharmacokinetic analysis (B-276). AACC, 2021. e-Pub 2021.
- Meng QH. Are Arterial Blood Samples Acceptable for Chemistry Testing in Laboratory Practice?. J Appl Lab Med 6:1380-1383, 2021. e-Pub 2021.
- Zhang YV, Wiencek J, Meng QH, Theel ES, Babic N, Sepiashvili L, Pecora ND, Slev P, Cameron A, Konforte D. AACC Practical Recommendations for Implementing and Interpreting SARS-CoV-2 EUA and LDT Serologic Testing in Clinical Laboratories. Clin Chem 67(9):1188-1200, 2021. e-Pub 2021. PMID: 34470034.
- Knight V, Long T, Meng QH, Linden MA, Rhoads DD. Variability in the Laboratory Measurement of Cytokines: A Longitudinal Summary of a College of American Pathologists Proficiency Testing Survey. Arch Pathol Lab Med 144(10):1230-1233, 2020. e-Pub 2020. PMID: 32401053.
- Fang B, Meng QH. The laboratory's role in combating COVID-19. Crit Rev Clin Lab Sci 57(6):400-414, 2020. e-Pub 2020. PMID: 32662342.
- Batth IS, Meng Q, Wang Q, Torres KE, Burks J, Wang J, Gorlick R, Li S. Rare osteosarcoma cell subpopulation protein array and profiling using imaging mass cytometry and bioinformatics analysis. BMC Cancer 20(1):715, 2020. e-Pub 2020. PMID: 32736533.
- Meng QH. Evolving hyperthyroidism?. Clin Biochem 75:83-84, 2020. e-Pub 2020. PMID: 31765636.
- Li J, Chang HM, Banchs J, Araujo DM, Hassan SA, Wagar EA, Yeh ETH, Meng QH. Detection of subclinical cardiotoxicity in sarcoma patients receiving continuous doxorubicin infusion or pre-treatment with dexrazoxane before bolus doxorubicin. Cardiooncology 6:1, 2020. e-Pub 2020. PMID: 32154027.
- Zhang X, Zhang R, Chen H, Wang L, Ren C, Pataer A, Wu S, Meng QH, Ha MJ, Morris J, Xi Y, Wang J, Zhang J, Gibbons DL, Heymach JV, Meric-Bernstam F, Minna J, Swisher SG, Roth JA, Fang B. KRT-232 and navitoclax enhance trametinib's anti-Cancer activity in non-small cell lung cancer patient-derived xenografts with KRAS mutations. Am J Cancer Res 10(12):4464-4475, 2020. e-Pub 2020. PMID: 33415011.
- Chen Y, Zhang R, Wang L, Correa AM, Pataer A, Xu Y, Zhang X, Ren C, Wu S, Meng QH, Fujimoto J, Jensen VB, Antonoff MB, Hofstetter WL, Mehran RJ, Pisimisis G, Rice DC, Sepesi B, Vaporciyan AA, Walsh GL, Swisher SG, Roth JA, Heymach JV, Fang B. Tumor characteristics associated with engraftment of patient-derived non-small cell lung cancer xenografts in immunocompromised mice. Cancer 125(21):3738-3748, 2019. e-Pub 2019. PMID: 31287557.
- Garnett E, Li J, Rajapakshe D, Tam E, Meng QH, Devaraj S. Efficacy of two vitamin D immunoassays to detect 25-OH vitamin D2 and D3. Pract Lab Med 17:e00130, 2019. e-Pub 2019. PMID: 31428669.
- j L, Satelli A, Bath I, Brownlee Z, Rojas C, Kopetz S, Wagar EA, Meng QH. Potential Role of Nuclear PD L1 Expression in Epithelial Mesenchymal Transitioned Circulating Tumor Cells as a Prognostic Marker in Prostate Cancer, 2019. e-Pub 2019.
- Garnett E, Li J, Rajapakshe D, Tam E, Meng QH, Devraj S. Comparison of Two Vitamin D immunoassays to Detect 25-OH Vitamin D2 and D3, 2019. e-Pub 2019.
- Qdaisat A, Soud RA, Wu CC, Rojas Hernandez CM, Li J, Meng QH, Abdel-Razeq H, Yeung SJ. Poor performance of D-Dimer in excluding venous thromboembolism among patients with lymphoma and leukemia. Haematologica 104(6):e265-e268, 2019. e-Pub 2019. PMID: 30630988.
- Qian X, Nguyen DT, Albers AE, Dong Y, Lyu J, Meng QH, Bi X, Graviss EA. An eight-year epidemiologic study of head and neck tuberculosis in Texas, USA. Tuberculosis (Edinb) 116S:S71-S77, 2019. e-Pub 2019. PMID: 31060959.
- Chen Q, Xiong C, Jia K, Jin J, Li Z, Huang Y, Liu Y, Wang L, Luo H, Li H, Meng QH, Li W. Hepatic transcriptome analysis from HFD-fed mice defines a long noncoding RNA regulating cellular cholesterol levels. J Lipid Res 60(2):341-352, 2019. e-Pub 2019. PMID: 30504232.
- Yan X, Zhang X, Wang L, Zhang R, Pu X, Wu S, Li L, Tong P, Wang J, Meng QH, Jensen VB, Girard L, Minna JD, Roth JA, Swisher SG, Heymach JV, Fang B. Inhibition of Thioredoxin/Thioredoxin Reductase Induces Synthetic Lethality in Lung Cancers with Compromised Glutathione Homeostasis. Cancer Res 79(1):125-132, 2019. e-Pub 2019. PMID: 30401714.
- Guan C, Zhang L, Wang S, Long L, Zhou H, Qian S, Ma M, Bai F, Meng QH, Lyu J. Upregulation of MicroRNA-21 promotes tumorigenesis of prostate cancer cells by targeting KLF5. Cancer Biol Ther 20(8):1149-1161, 2019. e-Pub 2019. PMID: 31002531.
- Baity M, Wang L, Correa AM, Zhang X, Zhang R, Pataer A, Wu S, Meng QH, Antonoff MB, Hofstetter WL, Mehran RJ, Rice DC, Roth JA, Sepesi B, Swisher SG, Vaporciyan AA, Walsh GL, Zhao M, Gu J, Fang B. Glutathione reductase (GSR) gene deletion and chromosome 8 aneuploidy in primary lung cancers detected by fluorescence in situ hybridization. Am J Cancer Res 9(6):1201-1211, 2019. e-Pub 2019. PMID: 31285952.
- Li J, Wagar EA, Meng QH. Comprehensive assessment of biotin interference in immunoassays. Clin Chim Acta 487:293-298, 2018. e-Pub 2018. PMID: 30296442.
- Li J, Ma J, Wagar EA, Liang D, Meng QH. A rapid ultra-performance LC-MS/MS assay for determination of serum unbound fraction of voriconazole in cancer patients. Clin Chim Acta 486:36-41, 2018. e-Pub 2018. PMID: 30016626.
- Li J, Meng QH. A Patient with Severe Hyperkalemia. Clin Chem 64(11):1673, 2018. e-Pub 2018. PMID: 30377182.
- Cao L, Lee CH, Ning J, Handy BC, Wagar EA, Meng QH. Combining prostate cancer antigen 3 (PCA3) and prostate-specific antigen (PSA) improves diagnostic accuracy in men at risk of prostate cancer. Arch Pathol Lab Med 142(9):1106-1112, 2018. e-Pub 2018. PMID: 29547000.
- Li J, Ma J, Liang D, Wagar EA, Meng QH. A rapid ultra-performance LC-MS/MS patients. IATDMCT 2018 Congress, 2018. e-Pub 2018.
- Li J, Wagar EA, Meng QH. Validation of high sensitive troponin T in Roche cobas. AACC, 2018. e-Pub 2018.
- Li J, Banchs J, Vejpongsa P, Araujo DM, Hassan SR, Wagar EA, Yeh ETH, Meng Q. Early detection of doxorubicin-induced cardiotoxicity with high-sensitivity. AACC, 2018. e-Pub 2018.
- Huang F, Chen Z, Chen H, Lu W, Xie S, Meng QH, Wu Y, Xia D. Cypermethrin Promotes Lung Cancer Metastasis via Modulation of Macrophage Polarization by Targeting MicroRNA-155/Bcl6. Toxicol Sci 163(2):454-465, 2018. e-Pub 2018. PMID: 29471534.
- Bai F, Zhou H, Ma M, Guan C, Lyu J, Meng QH. A novel RNA sequencing-based miRNA signature predicts with recurrence and outcome of hepatocellular carcinoma. Mol Oncol 12(7):1125-1137, 2018. e-Pub 2018. PMID: 29719937.
- Genzen JR, Murray DL, Abel G, Meng QH, Baltaro RJ, Rhoads DD, Delgado JC, Souers RJ, Bashleben C, Keren DF, Ansari MQ. Screening and Diagnosis of Monoclonal Gammopathies: An International Survey of Laboratory Practice. Arch Pathol Lab Med 142(4):507-515, 2018. e-Pub 2018. PMID: 29266967.
- Cao L, Lee CH, Ning J, Handy BC, Wagar EA, Meng QH. Combination of prostate cancer antigen 3 and prostate-specific antigen improves diagnostic accuracy in men at risk of prostate cancer. Arch Pathol Lab Med, 2018. e-Pub 2018. PMID: 29547000.
- Wang JF, Pu X, Zhang X, Chen K, Xi Y, Wang J, Mao X, Zhang J, Heymach JV, Antonoff MB, Hofstetter WL, Mehran RJ, Rice DC, Roth JA, Sepesi B, Swisher SG, Vaporciyan AA, Walsh GL, Meng QH, Shaw KR, Eterovic AK, Fang B. Variants with a low allele frequency detected in genomic DNA affect the accuracy of mutation detection in cell-free DNA by next-generation sequencing. Cancer 124(5):1061-1069, 2018. e-Pub 2018. PMID: 29178133.
- Li C, Zheng X, Li W, Bai F, Lyu J, Meng QH. Serum miR-486-5p as a diagnostic marker in cervical cancer: with investigation of potential mechanisms. BMC Cancer 18(1):61, 2018. e-Pub 2018. PMID: 29316891.
- Booth RA, McCudden CR, Balion CM, Blasutig IM, Bouhtiauy I, Rodriguez-Capote K, Catomeris P, Chan PC, Chen Y, Collier C, Hauff K, Kalra J, Li D, Lin DC, Lou AH, Meng QH, Morrison T, Pasic MD, Qureshi M, Randell E, Sohn KY, Thakur V, Thomas D, Thoni A, Tomalty C, Yang L, Zamkanei M. Candidate recommendations for protein electrophoresis reporting from the Canadian Society of Clinical Chemists Monoclonal Gammopathy Working Group. Clin Biochem 51:10-20, 2018. e-Pub 2018. PMID: 29061378.
- Wang J, Duan Y, Meng QH, Gong R, Guo C, Zhao Y, Zhang Y. Integrated analysis of DNA methylation profiling and gene expression profiling identifies novel markers in lung cancer in Xuanwei, China. PLoS One 13(10):e0203155, 2018. e-Pub 2018. PMID: 30286088.
- Li H, Meng QH, Noh H, Somaiah N, Torres KE, Xia X, Batth IS, Joseph CP, Liu M, Wang R, Li S. Cell-surface vimentin-positive macrophage-like circulating tumor cells as a novel biomarker of metastatic gastrointestinal stromal tumors. Oncoimmunology 7(5):e1420450, 2018. e-Pub 2018. PMID: 29721368.
- Li H, Meng QH, Noh H, Batth IS, Somaiah N, Torres KE, Xia X, Wang R, Li S. Detection of circulating tumor cells from cryopreserved human sarcoma peripheral blood mononuclear cells. Cancer Lett 403:216-223, 2017. e-Pub 2017. PMID: 28652021.
- Chen Y, Fang L, Li G, Zhang J, Li C, Ma M, Guan C, Bai F, Lyu J, Meng QH. Synergistic inhibition of colon cancer growth by the combination of methylglyoxal and silencing of glyoxalase I mediated by the STAT1 pathway. Oncotarget 8(33):54838-54857, 2017. e-Pub 2017. PMID: 28903386.
- Cao L, Ma Z, Ye Y, Wu X, Wagar EA, Meng QH. Genetic variants in the vascular endothelial growth factor pathway as potential markers of ovarian cancer risk, therapeutic response, and clinical outcome. American Association for Clinical Chemistry, 2017. e-Pub 2017.
- Satelli A, Batth I, Brownlee Z, Mitra A, Zhou S, Noh H, Rojas CR, Li H, Meng QH, Li S. EMT circulating tumor cells detected by cell-surface vimentin are associated with prostate cancer progression. Oncotarget 8(30):49329-49337, 2017. e-Pub 2017. PMID: 28521303.
- Wu X, Ye Y, Barcenas CH, Chow WH, Meng QH, Chavez-MacGregor M, Hildebrandt MA, Zhao H, Gu X, Deng Y, Wagar E, Esteva FJ, Tripathy D, Hortobagyi GN. Personalized Prognostic Prediction Models for Breast Cancer Recurrence and Survival Incorporating Multidimensional Data. J Natl Cancer Inst 109(7), 2017. e-Pub 2017. PMID: 28376179.
- Andersson BS, Thall PF, Valdez BC, Milton DR, Al-Atrash G, Chen J, Gulbis A, Chu D, Martinez C, Parmar S, Popat U, Nieto Y, Kebriaei P, Alousi A, de Lima M, Rondon G, Meng QH, Myers A, Kawedia J, Worth LL, Fernandez-Vina M, Madden T, Shpall EJ, Jones RB, Champlin RE. Fludarabine with pharmacokinetically guided IV busulfan is superior to fixed-dose delivery in pretransplant conditioning of AML/MDS patients. Bone Marrow Transplant 52(4):580-587, 2017. e-Pub 2017. PMID: 27991894.
- Chen Y, Fang L, Zhang J, Li G, Ma M, Li C, Lyu J, Meng QH. Blockage of Glyoxalase I Inhibits Colorectal Tumorigenesis and Tumor Growth via Upregulation of STAT1, p53, and Bax and Downregulation of c-Myc and Bcl-2. Int J Mol Sci 18(3), 2017. e-Pub 2017. PMID: 28282916.
- Tu H, Gu J, Meng QH, Kim J, Strom S, Davis JW, He Y, Wagar EA, Thompson TC, Logothetis CJ, Wu X. Low serum testosterone is associated with tumor aggressiveness and poor prognosis in prostate cancer. Oncol Lett 13(3):1949-1957, 2017. e-Pub 2017. PMID: 28454349.
- Cao L, Zhu W, Wagar EA, Meng QH. Biomarkers for monitoring chemotherapy-induced cardiotoxicity. Crit Rev Clin Lab Sci 54(2):1-15, 2017. e-Pub 2017. PMID: 28013560.
- Zhang Y, Xue Q, Pan G, Meng QH, Tuo X, Cai X, Chen Z, Li Y, Huang T, Duan X, Duan Y. Integrated Analysis of Genome-Wide Copy Number Alterations and Gene Expression Profiling of Lung Cancer in Xuanwei, China. PLoS One 12(1):e0169098, 2017. e-Pub 2017. PMID: 28056099.
- Baltaro R, Abel G, Bashleben C, Faix J, Genzen J, Meng QH, Murrary D, Shan M, Ansari M. Antinuclear Antibody (ANA) 2016 Statistical Analysis. A Comparison of Laboratory Practice and Result Reporting between the US and International labs. USCAP, 2017. e-Pub 2017.
- Genzen J, Murrary D, Abel G, Meng QH, Baltaro R, Faix J, Keren D, Ansari M. Screening and Diagnosis of Monoclonal Gammopathies: An International Survey of Laboratory Practice. USCAP, 2017. e-Pub 2017.
- Zhang J, Li G, Chen Y, Fang L, Guan C, Bai F, Ma M, Lyu J, Meng QH. Metformin Inhibits Tumorigenesis and Tumor Growth of Breast Cancer Cells by Upregulating miR-200c but Downregulating AKT2 Expression. J Cancer 8(10):1849-1864, 2017. e-Pub 2017. PMID: 28819383.
- Li C, Lyu J, Meng QH. MiR-93 Promotes Tumorigenesis and Metastasis of Non-Small Cell Lung Cancer Cells by Activating the PI3K/Akt Pathway via Inhibition of LKB1/PTEN/CDKN1A. J Cancer 8(5):870-879, 2017. e-Pub 2017. PMID: 28382150.
- Qiu W, Christakis I, Silva A, Bassett RL, Cao L, Meng QH, Gardner Grubbs E, Zhao H, Yao JC, Lee JE, Perrier ND. Utility of chromogranin A, pancreatic polypeptide, glucagon and gastrin in the diagnosis and follow-up of pancreatic neuroendocrine tumours in multiple endocrine neoplasia type 1 patients. Clin Endocrinol (Oxf) 85(3):400-7, 2016. e-Pub 2016. PMID: 27256431.
- Meng QH, Wagar EA. Where is the PSA?. Clin Chem 62(9):1281-2, 2016. e-Pub 2016. PMID: 27573457.
- He T, Zhou H, Li C, Chen Y, Chen X, Li C, Mao J, Lyu J, Meng QH. Methylglyoxal suppresses human colon cancer cell lines and tumor growth in a mouse model by impairing glycolytic metabolism of cancer cells associated with down-regulation of c-Myc expression. Cancer Biol Ther 17(9):955-65, 2016. e-Pub 2016. PMID: 27455418.
- Li C, Zhao L, Chen Y, He T, Chen X, Mao J, Li C, Lyu J, Meng QH. MicroRNA-21 promotes proliferation, migration, and invasion of colorectal cancer, and tumor growth associated with down-regulation of sec23a expression. BMC Cancer 16:605, 2016. e-Pub 2016. PMID: 27495250.
- Satelli A, Batth IS, Brownlee Z, Rojas C, Meng QH, Kopetz S, Li S. Potential role of nuclear PD-L1 expression in cell-surface vimentin positive circulating tumor cells as a prognostic marker in cancer patients. Sci Rep 6:28910, 2016. e-Pub 2016. PMID: 27363678.
- Cao L, Chen M, Phipps RA, Del Guidice RE, Handy BC, Wagar EA, Meng QH. Causes and impact of specimen rejection in a clinical chemistry laboratory. Clin Chim Acta 458:154-8, 2016. e-Pub 2016. PMID: 27166198.
- Meng QH. What's Missing?. Clin Chem 62(7):1037-8, 2016. e-Pub 2016. PMID: 27354571.
- Fan J, Tea MK, Yang C, Ma L, Meng QH, Hu TY, Singer CF, Ferrari M. Profiling of Cross-Functional Peptidases Regulated Circulating Peptides in BRCA1 Mutant Breast Cancer. J Proteome Res 15(5):1534-45, 2016. e-Pub 2016. PMID: 27058005.
- Chen X, Li C, He T, Mao J, Li C, Lyu J, Meng QH. Metformin inhibits prostate cancer cell proliferation, migration, and tumor growth through upregulation of PEDF expression. Cancer Biol Ther 17(5):507-14, 2016. e-Pub 2016. PMID: 26987032.
- Cao L, Wagar EA, Meng QH. A young boy with recurrent headache, lethargy, and hyponatremia. Clin Chim Acta 454:46-8, 2016. e-Pub 2016. PMID: 26747959.
- Guo Y, Zhang Y, Yang X, Lu P, Yan X, Xiao F, Zhou H, Wen C, Shi M, Lu J, Meng QH. Effects of Methylglyoxal and Glyoxalase I Inhibition on Breast Cancer Cells Proliferation, Invasion, and Apoptosis through Modulation of MAPKs, MMP9, and Bcl-2. Cancer Biol Ther 17(2):0, 2016. e-Pub 2016. PMID: 26618552.
- Bo J, Xie S, Guo Y, Zhang C, Guan Y, Li C, Lu J, Meng QH. Methylglyoxal Impairs Insulin Secretion of Pancreatic β-Cells through Increased Production of ROS and Mitochondrial Dysfunction Mediated by Upregulation of UCP2 and MAPKs. J Diabetes Res 2016:2029854, 2016. e-Pub 2016. PMID: 26779540.
- Cao L, Maloy CA, Munson S, Handy BC, Wagar EA, Meng QH. Performance evaluation of mycophenolic acid (MPA) on Siemens Dimension Xpand Plus chemistry analyzer. American Association for Clinical Chemistry. e-Pub 2016.
- Yang Z, Qdaisat A, Hu Z, Wagar EA, Reyes-Gibby C, Meng QH, Yeung SC. Cardiac Troponin Is a Predictor of Septic Shock Mortality in Cancer Patients in an Emergency Department: A Retrospective Cohort Study. PLoS One 11(4):e0153492, 2016. e-Pub 2016. PMID: 27077648.
- Tu H, Gu J, Meng QH, Kim J, Davis JW, He Y, Wagar EA, Thompson TC, Logothetis CJ, Wu X. Mitochondrial DNA copy number in peripheral blood leukocytes and the aggressiveness of localized prostate cancer. Oncotarget 6(39):41988-96, 2015. e-Pub 2015. PMID: 26515605.
- Meng QH, Wagar EA. A Patient with Persistent Lactation and Recurrent Hypercalcemia. Clin Chem 61(11):1328-31, 2015. e-Pub 2015. PMID: 26511349.
- Bo J, Guan Y, Guo Y, Xie S, Zhang C, Zhang H, Chen Z, Lu J, Meng QH. Impairment of Endothelial Cell Function Induced by Hemoglobin A1c and the Potential Mechanisms. Exp Clin Endocrinol Diabetes 123(9):529-35, 2015. e-Pub 2015. PMID: 26069073.
- Satelli A, Mitra A, Brownlee Z, Xia X, Bellister S, Overman MJ, Kopetz S, Ellis LM, Meng QH, Li S. Epithelial-mesenchymal transitioned circulating tumor cells capture for detecting tumor progression. Clin Cancer Res 21(4):899-906, 2015. e-Pub 2015. PMID: 25516888.
- Liu X, Meng QH, Ye Y, Hildebrandt MA, Gu J, Wu X. Prognostic significance of pretreatment serum levels of albumin, LDH and total bilirubin in patients with non-metastatic breast cancer. Carcinogenesis 36(2):243-248, 2015. e-Pub 2015. PMID: 25524924.
- Satelli A, Mitra A, Brownlee Z, Xia X, Bellister S, Overman MJ, Kopetz S, Ellis LM, Meng QH, Li S. Epithelial-mesencgymal transitioned circulating tumor cells capture for detecting tumor prigression. Clinical Cancer Research 21(4):899-906, 2015. e-Pub 2015.
- Satelli A, Brownlee Z, Mitra A, Meng QH, Li S. Circulating Tumor Cell Enumeration with a Combination of Epithelial Cell Adhesion Molecule- and Cell-Surface Vimentin-Based Methods for Monitoring Breast Cancer Therapeutic Response. Clin Chem 61(1):259-66, 2015. e-Pub 2015. PMID: 25336717.
- Meng QH, Wagar EA. Pseudohyperkalemia: A New Twist on an Old Phenomenon. Crit Rev Clin Lab Sci 16(2):1-11, 2015. e-Pub 2015. PMID: 25319088.
- Meng QH, Wagar EA. Laboratory approaches for the diagnosis and assessment of hypercalcemia. Crit Rev Clin Lab Sci 20(3):1-13, 2015. e-Pub 2015. PMID: 25327435.
- Meng QH, Wagar EA. Laboratory Approach for Diagnosis and Assessment of Hypercalcemia. Crit Rev Clin Lab Sci 52(3):107-119, 2015. e-Pub 2015. PMID: 25327435.
- Wu S, Wang L, Huang X, Cao M, Hu J, Li H, Zhang H, Sun X, Meng QH, Hofstetter WL, Roth JA, Swisher SG, Fang B. Prodrug oncrasin-266 improves the stability, pharmacokinetics, and safety of NSC-743380. Bioorg Med Chem 22(19):5234-40, 2014. e-Pub 2014. PMID: 25182964.
- Gan R, Yang Y, Yang X, Zhao L, Lu J, Meng QH. Downregulation of miR-221/222 enhances sensitivity of breast cancer cells to tamoxifen through upregulation of TIMP3. Cancer Gene Ther 21(7):290-296, 2014. e-Pub 2014. PMID: 24924200.
- Meng QH, Wagar EA. Severe hypophosphatemia in a 79-year-old man. Clin Chem 60(7):928-931, 2014. e-Pub 2014. PMID: 24973428.
- Meng QH, Handy B, Wagar E. A Case of Green Blood. Clinical Chemistry 60(4):695-696, 2014. e-Pub 2014. PMID: 24682689.
- Meng QH, Xu E, Hildebrandt MA, Liang D, Lu K, Ye Y, Wagar EA, Wu X. Genetic variants in the fibroblast growth factor pathway as potential markers of ovarian cancer risk, therapeutic response, and clinical outcome. Clin Chem 60(1):222-232, 2014. e-Pub 2014. PMID: 24146310.
- St Romain S, Bermudez I, Handy B, Wagar E, Meng QH. Performance Evaluation of Tumor CA15-3 on Roche Cobas e601 Immunoassay Analyzer. Clinical Chemistry, 2014. e-Pub 2014.
- Chen M, Handy BC, Wagar EA, Meng QH. Laboratory investigation of spurious hyperkalemia. Clinical Chemistry, 2014. e-Pub 2014.
- Chen M, Handy BC, Wagar EA, Meng QH. Factual or fictitious hypocalcemia?. Clinical Chemistry, 2014. e-Pub 2014.
- Yang X, Yang Y, Gan R, Zhao L, Li W, Zhou H, Wang X, Lu J, Meng QH. Down-regulation of mir-221 and mir-222 restrain prostate cancer cell proliferation and migration that is partly mediated by activation of SIRT1. PLoS One 9(6):e98833, 2014. e-Pub 2014. PMID: 24892674.
- Chen M, Phipps R, Del Guidice R, Wagar E, Meng QH. Investigation on Causes and Impact of Specimen Rejection in Clinical Chemistry Laboratory. Clinical Chemistry, 2014. e-Pub 2014.
- Meng QH, Wagar EA. An Unusual Case of Severe Hypophosphatemia. Clinical Chemistry 60:928-931, 2014. e-Pub 2014.
- Chen M, Calin G, Meng QH. Circulating microRNA as promising tumor biomarkers: opportunities and challenges for the clinical laboratory. Advances in Clinical Chemistry 67:189-214, 2014. e-Pub 2014.
- Meng QH, Handy B, Wagar EA. It's not easy being blue-green. Ann Lab Med 33(6):457-458, 2013. e-Pub 2013. PMID: 24205497.
- Bo J, Li W, Chen Z, Wadden DG, Randell E, Zhou H, Lu J, Meng QH. D-lactate: a novel contributor to metabolic acidosis and high anion gap in diabetic ketoacidosis. Clin Chem 59(9):1406-1407, 2013. e-Pub 2013. PMID: 23836843.
- Meng QH, Handy B, Wagar EA. Confirmatory Testing of Urine Ketones and Bilirubin: Still Necessary?. Arch Pathol Lab Med 137(8):1028-1029, 2013. e-Pub 2013. PMID: 23899056.
- Shu I, Pina-Oviedo S, Quiroga-Garza G, Meng QH, Wang P. Influence of vitamin D2 percentage on accuracy of 4 commercial total 25-hydroxyvitamin D assays. Clinical Chemistry 59(8):1273-1275, 2013. e-Pub 2013. PMID: 23695296.
- Wang Y, Chen Z, Chen J, Pan J, Zhang W, Pan Q, Ding H, Lin X, Wen X, Li Y, Meng Q. The diagnostic value of apolipoprotein E in malignant pleural effusion associated with non-small cell lung cancer. Clin Chim Acta 421:230-235, 2013. e-Pub 2013. PMID: 23523589.
- Mani S, Li H, Untereiner A, Wu L, Yang G, Austin RC, Dickhout JG, Š L, Meng QH, Wang R. Decreased Endogenous Production of Hydrogen Sulfide Accelerates Atherosclerosis. Circulation 127(25):2523-2534, 2013. e-Pub 2013. PMID: 23704252.
- Zhang J, Xie D, Zhou H, Fan R, Zhang L, Li C, Jin S, Meng QH, Lu J. The -590C/T polymorphism in the IL-4 gene and the risk of cancer: a meta-analysis. Tumour Biology 34:2261-2268, 2013. e-Pub 2013.
- Lu J, Ji J, Meng H, Wang D, Jiang B, Liu L, Randell E, Adeli K, Meng QH. The protective effect and underlying mechanism of metformin on neointima formation in fructose-induced insulin resistant rats. Cardiovasc Diabetol 12(1):58, 2013. e-Pub 2013. PMID: 23561047.
- Meng QH. Mass Spectrometry Applications in Clinical Diagnostics. Journal of Clinical and Experimental pathology, 2013. e-Pub 2013.
- Zhu S, Zhang L, Song H, Liu R, Xu Z, Bo J, Zhang H, Meng QH. Association of urinary albumin and serum high molecular weight-adiponectin with metabolic syndrome in patients with essential hypertension. Clin Chem Lab Med 50(11):2045-2047, 2012. e-Pub 2012. PMID: 23096762.
- Chen Z, Wang Y, Zeng A, Chen L, Wu R, Chen B, Chen M, Bo J, Zhang H, Peng Q, Lu J, Meng QH. The clinical diagnostic significance of cerebrospinal fluid d-lactate for bacterial meningitis. Clin Chim Acta 413(19-20):1512-1515, 2012. e-Pub 2012. PMID: 22713513.
- Zhang J, Li W, Liu J, Wu W, Ouyang H, Zhang Q, Wang Y, Liu L, Yang R, Liu X, Meng Q, Lu J. Polymorphisms in the vitamin D receptor gene and type 1 diabetes mellitus risk: An update by meta-analysis. Mol Cell Endocrinol 355:135-142, 2012. e-Pub 2012. PMID: 22361322.
- Ji JZ, Meng QH. Reply to "Haemoglobin, bilirubin, and lipid interference on Roche Cobas 6000 assays" (CCA-D-11-00941R1). Clin Chim Acta 413:342-343, 2012. e-Pub 2012.
- Wu WH, Li M, Wang Y, Ouyang HX, Wang L, Li CX, Cao YC, Meng QH, Lu JX. Aptasensors for rapid detection of Escherichia coli O157:H7 and Salmonella typhimurium. Nanoscale Res Lett 7(1):658, 2012. e-Pub 2012. PMID: 23190695.
- Oleschuk CJ, Prosser C, Dooley K, Higgins T, Meng Q, Don-Wauchope A, Fu L, Bunting P, Onuska K, LePage R, Pelletier P, Bouhtiauy I, Randell E. Position statement of the Canadian Society of Clinical Chemists and Canadian Association of Medical Biochemists on hemoglobin A1c measurement and reporting. Clinical Biochemistry 45:1036-1037, 2012. e-Pub 2012.
- Ahmed MS, Jadhav AB, Hassan A, Meng QH. Acute Phase Reactants as Novel Predictors of Cardiovascular Disease. ISRN Inflammation doi:10.5402/2012/953461(Article ID 953461):953461, 2012. e-Pub 2012. PMID: 24049653.
- Kavsak PA, Allen LC, Apple FS, Booth RA, Chan PC, Delvin E, Fraser A, Fu L, Gornall D, Collier C, Hill S, Hoffman B, Huang Y, Lavoie J, Lou A, Mattman A, McQueen M, Meng QH, Oleschuk C, Pudek M, Randell E, Sohn KY, Thorlacius L, Yip PM, Dahdah N, Devereaux PJ, Dhesy-Thind S, Hotte SJ, Worster A. Cardiac troponin testing in the acute care setting: Ordering, reporting, and high sensitivity assays--An update from the Canadian society of clinical chemists (CSCC). Clin Biochem 44(16):1273-1277, 2011. e-Pub 2011. PMID: 21851815.
- Ji JZ, Meng QH. Evaluation of the interference of hemolysis, icterus, and lipemia on Roche Cobas 6000 assays. Clin Chim Acta 412(17-18):1550-1553, 2011. e-Pub 2011. PMID: 21575617.
- Ahmed MS, Ji JZ, Meng QH. Lipoprotein-Associated Phospholipase A2: How Effective as a Risk Marker and as a Therapeutic Target?. Inflamm Allergy Drug Targets 10(4):236-246, 2011. e-Pub 2011. PMID: 21539512.
- Meng QH, Krahn J. Reverse pseudohyperkalemia in heparin plasma samples from a patient with chronic lymphocytic leukemia. Clin Biochem 44(8-9):728-730, 2011. e-Pub 2011. PMID: 21406192.
- Lu J, Zello GA, Randell E, Adeli K, Krahn J, Meng QH. Closing the Anion Gap: Contribution of D-lactate to Diabetic Ketoacidosis. Clin Chim Acta 412(3-4):286-291, 2011. e-Pub 2011. PMID: 21036159.
- Meng QH, Lu JX, Zello GA, Randell E, Adeli K, Krahn J. Closing the Gap: Correlation of D-lactate with Anion Gap and Metabolic Acidosis in Diabetic Ketoacidosis. Clinical Chemistry 56(A76), 2010. e-Pub 2010.
- Sohn N, Marcoux J, Mycyk T, Krahn J, Meng Q. Reply to letter. Perfusion 25:429-430, 2010. e-Pub 2010.
- Sohn N, Marcoux J, Mycyk T, Krahn J, Meng QH. The Impact of Different Biocompatible Coated Cardiopulmonary Bypass Circuits on Inflammatory Response and Oxidative Stress. Perfusion 24(4):231-237, 2009. e-Pub 2009. PMID: 19858237.
- Marcoux J, Sohn N, McNair E, Rosin M, Smith G, Lim H, Mycyk T, Meng Q. Outcomes comparison of 5 coated cardiopulmonary bypass circuits versus an uncoated control group of patients undergoing cardiac surgery. Perfusion 24:307-315, 2009. e-Pub 2009. PMID: 19906771.
- Meng QH, Zhu S, Sohn N, Mycyk T, Shaw SA, Dalshaug G, Krahn J. Release of Cardiac Biochemical and Inflammatory Markers in Patients on Cardiopulmonary Bypass Undergoing Coronary Artery Bypass Grafting. J Card Surg 23(6):681-687, 2008. e-Pub 2008. PMID: 18778302.
- Lu MP, Wang R, Song X, Wang X, Wu L, Meng QH. Modulation of methylglyoxal and glutathione by soybean isoflavones in mild streptozotocin-induced diabetic rats. Nutrition, Metabolism and Cardiovascular Disease 18(9):618-623, 2008. e-Pub 2008. PMID: 18060748.
- Zhu S, Liu Y, Wang L, Meng QH. Transforming growth factor-{beta}1 is associated with kidney damage in patients with essential hypertension: renoprotective effect of ACE inhibitor and/or angiotensin II receptor blocker. Nephrol Dial Transplant 23(9):2841-2846, 2008. e-Pub 2008. PMID: 18390891.
- Wu XC, Zhang WJ, Sammynaiken R, Meng QH, Yang Q, Zhan E, Liu Q, Yang W, Wang R. Non-functionalized Carbon Nanotube Binding with Hemoglobin. Colloids Surf B Biointerfaces 65(1):146-149, 2008. e-Pub 2008. PMID: 18375105.
- Lu MP, Wang R, Song X, Chibbar R, Wang X, Wu L, Meng QH. Dietary soy isoflavones increase insulin secretion and prevent the development of diabetic cataracts in streptozotocin-induced diabetic rats. Nutrition Research 28(7):464-471, 2008. e-Pub 2008. PMID: 19083447.
- Yang G, Wu L, Jiang B, Yang W, Qi J, Cao K, Meng Q, Mustafa AK, Mu W, Zhang S, Snyder SH, Wang R. H2S as a physiologic vasorelaxant: Hypertension in mice with deletion of cystathionine gamma-lyase. Science 322:587-590, 2008. e-Pub 2008. PMID: 18948540.
- Meng QH, Krahn J. Lithium heparinized blood-collection tubes give falsely low albumin results with an automated bromcresol green method in haemodialysis patients. Clin Chem Lab Med 46(3):396-400, 2008. e-Pub 2008. PMID: 18254716.
- Ye Z, Ahmed KA, Hao S, Zhang X, Xie Y, Munegowda MA, Meng Q, Chibbar R, Xiang J. Active CD4+ helper T cells directly stimulate CD8+ cytotoxic T lymphocyte responses in wild-type and MHC II gene knockout C57BL/6 mice and transgenic RIP-mOVA mice expressing islet beta-cell ovalbumin antigen leading to diabetes. Autoimmunity 41:501-511, 2008. e-Pub 2008. PMID: 18855194.
- Wang H, Meng QH, Gordon JR, Khandwala H, Wu L. Proinflammatory and proapoptotic effects of methylglyoxal on neutrophils from patients with type 2 diabetes mellitus. Clin Biochem 40(16-17):1232-1239, 2007. e-Pub 2007. PMID: 17825811.
- Meng QH, Yang GD, Yang W, Jiang B, Wu L, Wang R. Protective effect of hydrogen sulfide on balloon injury-induced neointima hyperplasia in rat carotid arteries. Am J Pathol 170(4):1406-1414, 2007. e-Pub 2007. PMID: 17392179.
- Lu MP, Wang R, Krahn J, Chobbar R, Wu L, Meng QH. Effects of Soybean Isoflavones on Glucose Metabolism and Prevention of Cataracts in Streptozotocin Induced Diabetic Rats, 2007. e-Pub 2007.
- Wu XC, Zhang WJ, Sammynaiken R, Meng QH, Wu DQ, Yang Q, Yang W, Zhang EM, and Wang R. Measurement of low concentration and nano-quantity hydrogen sulfide in sera using unfunctionalized carbon nanotubes. Meas. Sci. Technol 20(105801):6, 2007. e-Pub 2007.
- Wan B, Li H, Chong P, Chan MK, Matteliano S, Verjee Z, Kyriakopoulou L, Meng QH, Adeli K. Analytical Evaluation and Implementation of the DPC Immulite 2500 Analyzer in a Paediatric Tertiary care Setting. Clinical Biochemistry, 2007. e-Pub 2007.
- Yan SK, Chang T, Wang H, Wu L, Wang R, Meng QH. Effects of hydrogen sulfide on homocysteine-induced oxidative stress and nitric oxide production in vascular smooth muscle cells. Biochem Biophys Res Commun 351(2):485-491, 2006. e-Pub 2006. PMID: 17069760.
- Wang H, Meng QH, Chang T, Wu L. Fructose induced peroxynitrite production is mediated by methylglyoxal in vascular smooth muscle cells. Life Sci 79(26):2448-2454, 2006. e-Pub 2006. PMID: 16950408.
- Zhu S, Su G, Meng QH. Inhibitory Effects of Micronized Fenofibrate on Carotid Atherosclerosis in Patients with Essential Hypertension. Clin Chem 52(11):2036-2042, 2006. e-Pub 2006. PMID: 16990410.
- Wang R, Shamloul R, Wang X, Meng Q, Wu L. Sustained normalization of high blood pressure in spontaneously hypertensive rats by implanted hemin pump. Hypertension 48(4):685-692, 2006. e-Pub 2006. PMID: 16940218.
- Meng QH, Zhu S, Booth C, Stevens L, Bertsch B, Qureshi M, Kalra J. Impact of the Cardiac Troponin Testing Algorithm on Excessive and Inappropriate Troponin Test Requests. Am J Clin Pathol 126(2):1-5, 2006. e-Pub 2006. PMID: 16891193.
- Hao S, Ye Z, Li F, Meng Q, Qureshi M, Yang J, Xiang J. Epigenetic transfer of metastatic activity by uptake of highly metastatic B16 melanoma cell-released exosomes. Exp Oncol 28(2):126-131, 2006. e-Pub 2006. PMID: 16837903.
- Yan SK, Luo D, Song YH, Li HY, Cheng XQ, Xiao XH, Meng QH. Hyperhomocysteinemia, MTHFR C677T and CBS 844ins68 gene polymorphism in type 2 diabetes melittus with coronary heart disease in Han Chinese. Clinical Chemistry S6(B62), 2006. e-Pub 2006.
- Meng QH. Pediatric reference intervals: Critical gap analysis and establishment of a national intiative. Clinical Biochemistry 39:559-560, 2006. e-Pub 2006.
- Meng QH, Yang G, Yang W, Jiang B, Wu L, Wang R. A Novel Mechanism of Atherosclerosis: The Protective Role of Hydrogen Sufide in the Pathogenesis of Atherosclerosis. Clinical Biochemistry 1093, 2006. e-Pub 2006.
- Shamloul R, Wu L, Wang X, Meng QH, Wang R. Sustained normalization of high blood pressure in spontaneously hypertensive rats by implented hemin pump. Exp Clin Cardiol 11(1), 2006. e-Pub 2006.
- Zhu S, Meng QH. Association of angiotensin II type 1 receptor gene polymorphism with carotid atherosclerosis. Clin Chem Lab Med 44(3):282-284, 2006. e-Pub 2006. PMID: 16519598.
- Meng QH, Zhu SM, Booth C, Stevens L, Bertsch B, Qureshi M, Kalra J. Impact of a Cardiac Troponin Testing Algorithm on Excessive and Inappropriate Troponin Test Requests. Clinincal Biochemistry 39(1093), 2006. e-Pub 2006.
- Meng QH, Irwin WC, Fesser J, Massey KL. Interference of Ascorbic Acid with Chemical Analytes. Ann Clin Biochem 42(6):475-477, 2005. e-Pub 2005. PMID: 16259800.
- Paparella D, Radi OA, Meng QH, Venner T, Teoh K, Young E. The effects of high-dose heparin on inflammatory and coagulation parameters following cardiopulmonary bypass. Blood Coagulation and Fibrinolysis 16(5):323-328, 2005. e-Pub 2005. PMID: 15970715.
- Meng QH, Gauthier D. Simultaneous analysis of citalopram and desmethylcitalopram by HPLC following solid-phase extraction. Clinical Biochemistry 38(3):282-285, 2005. e-Pub 2005. PMID: 15708552.
- Meng QH, Irwin WC, Visvanathan K. Vitamin C and aberrant electrolyte results. Clin Chem Lab Med 43(4):454-456, 2005. e-Pub 2005. PMID: 15899664.
- Meng QH, Taylor C, Donahoe M, Ryan ED. Evaluation of Tumor Marker on Roche Modular E170 Immunoassay System. Clinical Biochemistry 37(724), 2004. e-Pub 2004.
- Meng QH, Luxton G. Recurrent Confusion and Seizures in an Adult Male. Laboratory Medicine 35:478-483, 2004. e-Pub 2004.
- Courtman DW, Franco CD, Meng QH, Bendeck MP. Inward Remodeling of the Rabbit Aorta is Blocked by the Matrix Metalloproteinase Inhibitor Doxycycline. Journal of Vascular Ressearch 41:157-165, 2004. e-Pub 2004. PMID: 15004435.
- Meng QH, Hill S, Luxton G. The Case of the Newborn with Ambiguous Genitalia. Laboratory Medicine 34:532-534, 2003. e-Pub 2003.
- Meng QH, Hill S, Luxton G. Diarrhea, Abdominal Pain, Weight Loss, and Malnutrition in an Adult Woman. Laboratory Medicine 34(581-584), 2003. e-Pub 2003.
- Meng QH, and Potter MA. A Simplified Method for Maternal Urine Dehydrosteroid Analysis on GC/MS. Clinical Biochemistry 36(497), 2003. e-Pub 2003.
- Meng QH, Gauthier D, Gupta RN. Simultaneous analysis of citalopram and desmethylcitalopram by HPLC following solid-phasw extraction. Clinical Biochemistry 35(2):166, 2002. e-Pub 2002.
- Meng QH, Rezaei E, Courtman DW. Inward Eutrophic Remodeling after Sequential Injury in the Rabbit Aorta: Role of Extrinsic Coagulstion and Extracellular Matrix Accumulation. Arteriosclerosis, Trombosis and Vascular Biology 21(676), 2001. e-Pub 2001.
- Bendeck MP, Meng QH, Franco C, Courtman DW. Inward Vessel Remodeling is Blocked by the MMP Inhibitor Doxycycline. Arteriosclerosis, Thrombosis and Vascular Biology 21(677), 2001. e-Pub 2001.
- Liu JQ, Heikkilä P, Meng QH, Kahri AI, Tikkanen MJ, Voutilainen R. Expression of low and high density lipoprotein receptor genes in human adrenals. Eur J Endocrinol 142(6):677-682, 2000. e-Pub 2000. PMID: 10832106.
- Lewis PT, Wähälä K, Hoikkala A, Mutikainen I, Meng QH, Adlercretz H, and Tikkanen MJ. Synthesis of antioxidant isoflavone fatty acid esters. Tetrahedron 56:7805-7810, 2000. e-Pub 2000.
- Meng QH, Höckerstedt A, Heinonen S, Wähälä K, Adlercreutz H, Tikkanen MJ. Antioxidant protection of lipoproteins containing estrogens: in vitro evidence for LDL and HDL as estrogen carriers. Biochimica Biophysica Acta 1439(3):331-340, 1999. e-Pub 1999. PMID: 10446421.
- Meng QH, Lewis P, Wähälä K, Adlercreutz H, Tikkanen MJ. Incorporation of esterified soybean isoflavones with antioxidant activity into low-density lipoprotein. Biochimica Biophysica Acta 1438(3):369-376, 1999. e-Pub 1999. PMID: 10366779.
- Meng QH, Wähälä K, Adlercreutz H, Tikkanen MJ. Antiproliferative efficacy of lipophilic soy isoflavone phytoestrogens delivered by low-density lipoprotein particles into cultured U937 cells. Life Sciences 65(16):1695-1705, 1999. e-Pub 1999. PMID: 10573187.
- Meng QH. Lipid lowering effect of Simvastatin. Chinese Journal of Cardiovascular Medicine 7:32-38, 1998. e-Pub 1998.
- Meng QH, Pajukanta P, Valsta L, Aro A, Pietinen P, Tikkanen MJ. Influence of apolipoprotein A-1 promoter polymorphism on lipid levels and responses to dietary changes in Finnish adults. Journal of Internal Medicine 241(5):373-378, 1997. e-Pub 1997. PMID: 9183304.
- Meng QH, Pajukanta P, Ilmonen M, Schuster H, Schewe CK, Andersson LC, Tikkanen MJ. Analysis of novel apolipoprotein B mutations using a modified U937 cell line LDL binding assay. Clinica Chimica Acta 256(1):27-36, 1996. e-Pub 1996. PMID: 8960785.
- Borisenko SA, Meng QH, Rauhala P, Männistö PT. Neurochemical mediators of anxiety have inconsistent effects on hypothalamic self-stimulation in rats. Pharmacology Toxicology 78(5):354-360, 1996. e-Pub 1996. PMID: 8737973.
- Meng QH. Treatment of Persistent Hiccup: a novel application of Chlorpromazine. Chinese Journal of Applied Medicine 14:148-150, 1992. e-Pub 1992.
- Meng QH, Zhang WB. Hematological change of different types of hepatitis. Journal of Jiangsu Occupational Medicine 12:34-36, 1992. e-Pub 1992.
Review Articles
- Chen, L, Meng, QH. Advancing Laboratory Diagnostics for Future Pandemics. Pathogens 14(11), 2025. e-Pub 2025. PMID: 41305372.
Professional Educational Materials
- Meng PhD QH. Hypercalcemia: Causes and Laboratory Investigation, 2018.
- Meng PhD QH, MD, DABCC, FCACB. Hypercortisolism, 2018.
Other Articles
- Chen L, Li J, Meng QH Metabolic and Cardiac Complications in a Case of Adrenal Carcinoma. The Electronic Journal of the International Federation of Clinical Chemistry and Laboratory Medicine 36(4):575-580, 2025. PMID: 41459168.
- Gan, R, Yang, Y, Yang, X, Zhao, L, Lu, J, Meng, QH Correction to: Downregulation of miR-221/222 enhances sensitivity of breast cancer cells to tamoxifen through upregulation of TIMP3. Cancer Gene Therapy 30(11):1582, 2023. PMID: 37789076.
Abstracts
- Meng QH, Shrivastav D, Ali Beg MM, Meng QH. Exploring Natural Products to Control Type 2 Diabetes Mellitus through Targeting Advanced Glycation End Products. Iranian Journal of Diabetes and Obesity 16(3), 2024. e-Pub 2024.
- Meng QH, Halfdanarson TR, Bornhorst J, Jann H, Shaheen S, Shi RZ, Halperin DM. Chromogranin A as surveillance biomarker in patients with carcinoids: CASPAR. Journal of Clinical Oncology 41(16), 2023.
- Racine-Brzostek SE, Yee JK, Sukhu A, Qiu Y, Rand S, Barone PD, Hao Y, He S Yang, Meng QH, Apple FS, Shi Y, Chadburn A, Golden E, Formenti SC, Cushing M, Zhao Z. Rapid, robust, and sustainable antibody responses to mRNA COVID-19 vaccine in convalescent COVID-19 individuals. JCI Insight 6(20):e151477, 2021. e-Pub 2021. PMID: 34499052.
- Meng QH, Handy BC, Wagar EA. Falsely elevated tacrolimus concentrations on the Dimension Xpand. Clin Biochem 48(16-17):1210, 2015. e-Pub 2015. PMID: 26160209.
- Meng QH, St Romain S, Bermudez IO, Handy BC, Wagar EA. Laboratory Investigations on Fasely Elevated Tacrolimus Concentrations on the Dimension Xpand(S254):B-337. e-Pub 2015.
- Meng QH, Ji J, Wang D, Jiang B, Liu L, Adeli K, Lu J. Metformin Attrnuates Neointimal Formation in Fructose-Induced Insulin Resistant Rats: the Pathological Role of Methylglyoxal in Stenoisi. Clinical Chemistry B08(A62), 2012. e-Pub 2012.
- Lu J, Randell E, Han Y, Adeli K, Krahn J, Meng QH. Increased plasma methylglyoxal level, inflammation, and vascular endothelial dysfunction in diabetic nephropathy. Clin Biochem 44(4):307-311, 2011. e-Pub 2011. PMID: 21126514.
- Meng QH, Zhang J, Krahn J. Evaluation of the Interference of Hemoglobin, Bilirubin, and Lipids on Roche Cobas 6000 Assays. Clinical Chemistry 57(A125-126), 2011. e-Pub 2011.
- Zhu S, Huang KL, Wang LQ, Meng QH. Increased Microalbumin in Urine and Decreased Serum High Molecular Weight-adiponectin in Hypertensive Patients with Metabolic Syndrome. Clinical Chemistry 57(A157), 2011. e-Pub 2011.
- Meng QH, Adeli K, Zello GA, Porter WH, Krahn J. Elevated Lactate in Ethylene Glycol Poisoning: True or false?. Clin Chim Acta 411(7-8):601-604, 2010. e-Pub 2010. PMID: 20096388.
- Meng QH, Adeli K, Zello GA, Porter WH, Krahn J. Elevated Lactate in Ethylene Glycol Poisoning: True or False?. Clinical Biochemistry 43(780), 2010. e-Pub 2010.
- Meng QH, Lu JX, Randell E, Adeli K, Krahn J. Increased Plasma Methylglyoxal Level and Inflammation are Associated with Diabetic Nephropathy. Clinical Biochemistry 43(780), 2010. e-Pub 2010.
- Lu JX, Meng QH, Randell E, Adeli K, Krahn J. Increased Plasma Levels of Methylglyoxal and Adhesion Molecules in Diabetic Ketoacidosis. Clinical Chemistry 56(A58), 2010. e-Pub 2010.
- Meng QH, Lu JX, Randell E, Adeli K, Krahn J. Increased Plasma Methylglyoxal Level, Inflammation, and Vascular Endothelial Dysfunction in Diabetic Nephropathy. Clinical Chemistry 56(A59), 2010. e-Pub 2010.
- Meng QH, Lu JX, Zello GA, Randell E, Adeli K, Krahn J. Search for the Missing Gap: D-Lactate is Associated with Elevated Anion Gap and Diabetic Ketoacidosis. Clinical Biochemistry 43(779), 2010. e-Pub 2010.
- Meng QH, Chibbar R, Pearson D, Kappel J, Krahn J. Heat-insoluble cryoglobulin in a patient with essential type II cryoglobulinemia and cryoglobulin-occlusive membranoproliferative glomerulonephritis: Case report and literature review. Clin Chim Acta 406(1-2):170-173, 2009. e-Pub 2009. PMID: 19463798.
- Meng QH, Sohn N, Marcoux J, Mycyk T, Krahn J. Comparison of effects of five biocompatible coating materials of cardiopulmonary bypass circuits on inflammatory response during coronary artery bypass grafting 55(S6):B17, 2009. e-Pub 2009.
- Meng QH, Rempel D, Qureshi M, Kalra J, Krahn J. Implementation of chemical urinalysis criteria to eliminate unnecessary urine microscopic analysis 55(S6):A93, 2009. e-Pub 2009.
- Meng QH, Mei-Ping L, Rui W, Xiuyuan S, Rajni C, Xiaoxia W, Lingyun W. Beneficial Effects of Soy Isoflavones on Insulin Secretion, Glucose Control, and Cataract Prevention in Streptozotocin-induced Diabetic Rats 54(S6):B65, 2008. e-Pub 2008.
- Meng QH, Zhu S, Liu Y, Wang L. Transforming growth factor-Β1 is a potential marker for kidney damage in patients with essential hypertension: renoprotectiveeffect of ACE inhibitor and/or angiotensin II receptor blocker 54(S6):A113, 2008. e-Pub 2008.
- Yan SK, Zhu S, Mycyk T, Shaw S, Dalshaug G, Krahn J, Meng QH. Release of Oxidative Stress and Inflammatory Markers in Patients Following Coronary Artery Bypass Grafting with Cardiopulmonary Bypass. Clinical Chemistry S6(A61), 2007. e-Pub 2007.
- Meng QH, Krahn J. Heparin Negatively Interferes With Albumin Measurement by Bromcresol Green Method 53(S6):C74, 2007. e-Pub 2007.
- Yan SK, Wang H, Sohn N, Wu L, Meng QH. Elevated plasma methylglyoxal level and oxidative stress in type 2 diabetes with nephropathy 53(S6):D104, 2007. e-Pub 2007.
- Meng QH, Wilde B, Brenaut C, La Rocque H, Qureshi M, Kalra J. Evaluation of Analytical Performance of the Thermo Infinity Lithium Assay 52(S6):E103, 2006. e-Pub 2006.
- Yan SK, Cheng XQ, Song YH, Xiao XH, Bi N, Chen BS, Meng QH 52(S6):C134, 2006. e-Pub 2006.
- Meng QH, Yang G, Yang W, Jiang B, Wu L, Wang R. The Protective Role of Hydrogen Sulfide in the Pathogeneisi of Atherosclerosis 52(S6):D44, 2006. e-Pub 2006.
- Wilde B, Meng QH, Brenaut C, La Rocque H, Qureshi M, Kalra J. Evaulation of the Bio Rad Variant II Haemoglobin A1c Method 52(S6):E102, 2006. e-Pub 2006.
- Meng QH, Irwin WC, Massey KL. Interference of ascorbic acid on chemical analytes on Beckman Synchron 51(S6):A134, 2005. e-Pub 2005.
- Meng QH, Bertsch B, Qureshi M, Kalra J, Massey KL. Influence of thyroid hormones on lipid levels in geriatric patients 51(S6):C89, 2005. e-Pub 2005.
- Qureshi M, Booth C, Kalra J, Meng QH, Massey L. Evaluation of the Beckman Synchron LX PRO High Sensitivity C-reactive Protein Assay 51(S6):A10, 2005. e-Pub 2005.
- Meng QH, Luxton G. Elevation of High-Sensitive C-Rective Protein Levels in Patients with Coronary Artery Disease 50(S6):A12, 2004. e-Pub 2004.
- Meng QH, Balion CM, Grey VL. Serum cardiac troponin I in rhabdomyolysis 49(S6):B10, 2003. e-Pub 2003.
- Meng QH, Paparella D, Teoh K, Venner T, Young E. Cardioprotective Effects of High Dose Heparin During Cardiopulmonary Bypass. Clinical Biochemistry 36(489), 2003. e-Pub 2003.
- Courtman DW, Edvinsson L, Edvinsson ML Badaei S, Meng QH, Ward ME, Quan A, Errett L. VasoCare™ therapy improves endothelial function in Watanabe rabbits and in humans with advanced atherosclerosis. Circulation 102(18):265, 2000. e-Pub 2000.
- Meng QH, Wahala K, Adlercreutz H, Lewis PT, Tikkanen MJ. Effect of Soy Phytoestrogen Intake on Low-Density Lipoprotein0Induced U937 Cell Proliferation, 1998. e-Pub 1998.
- Meng QH, Herman A, Anna H, Tikkanen Matti J. Antioxidant protection of lipoprotein containing estrogens, 1998. e-Pub 1998.
- Lewis P, Wahala K, Meng QH, Adlercreutz H, Tikkanen MJ. Synthesis of Antioxidant Isoflavone Acid Esters, 1998. e-Pub 1998.
- Meng QH, Adlercreutz H, Wahala K, Tikkanen MJ. Low density lipoprotein-bound isoflavonoid genistein: Structure-antioxident activity relationships. Atherosclerosis 134(1,2):168, 1997. e-Pub 1997.
Book Chapters
- Li, J, Meng, QH, Ramanathan, LV. Overview of traditional and nontraditional tumor markers, 1-29, 2022.
- Meng, QH, Qian, X. Ethics, 39-44, 2021.
- Meng Q. Ethics: informed consent, patient privacy. In: Clinical Molecular Diagnostics, 2020.
- Meng Q. Self-Assessment in Clinical Laboratory Science III. In: Tumor Markers, 2020.
- Chen M, Meng QH. Chemotherapy drug monitoring by liquid chromatography-tandem mass spectrometry. In: Clinical Application of LCMS/MS, 2014.
- Borisenko SA, Rauhala P, Meng QH, Männistö PT. Effect of some Antagonists on the reaction of hypothalamic self-stimulation. In: Biological Basis of Individual Sensitivity to Psychotropic Drugs. Harwood Academic Publishers, 243-257, 1994.
- Meng QH, Holdenrieder S. Pitfalls in Testing for Common Tumor Markers. In: Accurate Results in the Clinical Laboratory: A Guide to Error Detection and Correction. 2nd Edition (2025). 2nd.
Patient Reviews
CV information above last modified February 20, 2026